The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

Hepatitis B,Chronic Clinical Trial

Official title: Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

Status Recruiting

Clinical Trial Summary

More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.

Clinical Trial Description

n/a

Study Design

Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Carcinoma, Hepatocellular
• Carcinoma,Hepatocellular
• Hepatitis
• Hepatitis A
• Hepatitis B, Chronic
• Hepatitis B,Chronic

• NCT number: NCT01310062
• Study type: Observational
• Source: Ministry of Health, Malaysia
• Contact: Clinical Research Centre
• Phone: +603-40439300
• Email: shanthini@crc.gov.my
• Status: Recruiting
• Phase: N/A
• Start date: August 2010
• Completion date: August 2012